Results 201 to 210 of about 1,320,827 (304)

Reconstructed Copper Compound by Cerium Leaching for Enhanced Electrochemical CO2‐to‐Ethylene Conversion

open access: yesAdvanced Science, EarlyView.
A Ce‐incorporated Cu oxide can achieve prominent selective CO2‐to‐ethylene performance by reconstructing to oxygen‐contained Cu with an optimized Cu0/(Cu++Cu2+) ratio and electronic structure through Ce leaching and in situ reduction. The interactions between the reconstructed structure and leached Ce improve the CO2‐to‐ethylene by enhancing water ...
Jinxian Feng   +8 more
wiley   +1 more source

Validating and leveraging non-SARS-CoV-2 respiratory infection as a negative control outcome in a phase 3 COVID-19 vaccine trial with extended observational follow-up. [PDF]

open access: yesAm J Epidemiol
Ashby E   +14 more
europepmc   +1 more source

Dependence of SARS-CoV-2 (COVID-19) inactivation ability on the crystallinity level of transparent Cu2O thin films

open access: hybrid, 2022
Hsiang-Jung Wu   +7 more
openalex   +1 more source

Nanoscale Mapping of the Subcellular Glycosylation Landscape

open access: yesAdvanced Science, EarlyView.
Using multiplexed super‐resolution imaging with fluorophore‐labeled lectins, this study reports intracellular glycosylation at the nanoscale across organelles and synaptic specializations. Extending glycan analysis beyond the cell surface, Glyco‐STORM reveals distinct glycosylation nanodomains in the ER, Golgi, lysosomes, and synaptic sites.
Helene Gregoria Schroeter   +4 more
wiley   +1 more source

Elevated mortality and upregulated SARS-CoV-2-associated pathways in innate and adaptive immune cells from individuals with Down syndrome. [PDF]

open access: yesPLoS One
Victorino DB   +17 more
europepmc   +1 more source

Differences in SARS-COV-2 seroprevalence in the population of Cusco, Peru

open access: gold, 2023
Charles Huamaní   +16 more
openalex   +1 more source

Computational Design and Glycoengineering of Interferon‐Lambda for Nasal Prophylaxis Against Respiratory Viruses

open access: yesAdvanced Science, EarlyView.
This study presents an engineered human interferon‐lambda (hIFN‐λ) as an intranasal prophylactic against respiratory viruses. By combining AI‐guided backbone redesign and glycoengineering, the authors developed a thermostable, protease‐resistant, and scalable variant with improved mucosal penetration.
Jeongwon Yun   +12 more
wiley   +1 more source

PD‐1 Inhibits CD4+ TRM‐Mediated cDC1 Mobilization via Suppressing JAML in Human NSCLC

open access: yesAdvanced Science, EarlyView.
CD4+ tissue‐resident memory T cells (TRMs) in non‐small cell lung cancer recruit conventional type 1 dendritic cells via XCL1‐XCR1 signaling, orchestrating antitumor immunity. The costimulatory molecule JAML is essential for this process. PD‐1 blockade restores JAML expression and cDC1 mobilization, while JAML agonists synergize with anti‐PD‐1 therapy,
Zheyu Shao   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy